Inhalation of LPS induces inflammatory airway responses mimicking characteristics of chronic obstructive pulmonary disease

Clinical Physiology and Functional Imaging

Volumn 32, Issue 1, 2012, Pages 71-79

  Korsgren, Magnus ^a   Linden, Margareta ^b   Entwistle, Neil ^c   Cook, Jason ^c   Wollmer, Per ^a   Andersson, Morgan ^a   Larsson, Bengt ^a,b   Greiff, Lennart ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

^c ASTRAZENECA   (United Kingdom)

Author keywords

Airway inflammation; C reactive protein; Endotoxin; Neutrophil elastase; Neutrophils; Tumour necrosis factor

Indexed keywords

C REACTIVE PROTEIN; DESMOSINE; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD ANALYSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; FEVER; HUMAN; HUMAN EXPERIMENT; LEUKOCYTE; MALAISE; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; SHIVERING; SPUTUM ANALYSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; URINALYSIS;

ADMINISTRATION, INHALATION; ALPHA 1-ANTITRYPSIN; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DESMOSINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FORCED EXPIRATORY VOLUME; HUMANS; LEUKOCYTE ELASTASE; LIPOPOLYSACCHARIDES; LUNG; PNEUMONIA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPIROMETRY; SPUTUM; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VITAL CAPACITY;

EID: 83555174551     PISSN: 14750961     EISSN: 1475097X     Source Type: Journal    
DOI: 10.1111/j.1475-097X.2011.01058.x     Document Type: Article

References (34)

1. Aaron SD, Angel JB, Lunau M, Wright K, Fex C, Le Saux N, Dales RE. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001); 163: 349-355.
2. Barnes PJ. Alveolar macrophages as orchestrators of COPD. COPD (2004); 1: 59-70.
3. Boschetto P, Quintavalle S, Zeni E, Leprotti S, Potena A, Ballerin L, Papi A, Palladini G, Luisetti M, Annovazzi L, Iadarola P, De Rosa E, Fabbri LM, Mapp CE. Association between markers of emphysema and more severe chronic obstructive pulmonary disease. Thorax (2006); 61: 1037-1042.
4. Fill JA, Brandt JT, Wiedemann HP, Rinehart BL, Lindemann CF, Komara JJ, Bowsher RR, Spence MC, Zeiher BG. Urinary desmosine as a biomarker in acute lung injury. Biomarkers (2006); 11: 85-96.
5. Fiorenza D, Viglio S, Lupi A, Baccheschi J, Tinelli C, Trisolini R, Iadarola R, Luisetti M, Snider GL. Urinary desmosine excretion in acute exacerbations of COPD: a preliminary report. Respir Med (2002); 96: 110-114.
6. Hacievliyagil SS, Gunen H, Mutlu LC, Karabulut AB, Temel I. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease. Respir Med (2006); 100: 846-854.
7. 2-macroglobulin. Thorax (1997); 52: 964-968.
8. 1-antitrypsin deficiency (PiZ). Am J Respir Crit Care Med (1999); 160: 1968-1975.
9. Hohlfeld JM, Schoenfeld K, Lavae-Mokhtari M, Schaumann F, Mueller M, Bredenbroeker D, Krug N, Hermann R. Roflumilast attenuates pulmonary inflammation upon segmental endotoxin challenge in healthy subjects: a randomized placebo-controlled trial. Pulm Pharmacol Ther (2008); 21: 16-23.
10. Jie Z, Cai Y, Yang W, Jin M, Zhu W, Zhu C. Protective effects of alpha-1-antitrypsin on acute lung injury in rabbits induced by endotoxin. Chin Med J (Engl) (2003); 116: 1678-1682.
11. Keatings VM, Barnes PJ. Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. Am J Respir Crit Care Med (1997); 155: 449-453.
12. Krug N, Larbig M, Bonner J, Mueller M, Erpenbeck VJ, Schaumann F, Lloyd P, Hohlfeld JM, Pascoe S. Anti-MCP-1-monoclonal antibody (ABN912) attenuates LPS-induced monocyte recruitment into the lung in patients with COPD. Proc Am Thorac Soc (2006); 3: A849.
13. Lacoste JY, Bousquet J, Chanez P, van Vyve T, Simony-Lafontaine J, Lequeu N, Vic P, Enander I, Godard P, Michel FB. Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol (1993); 92: 537-548.
14. 1-antitrypsin inhibits the lethal response to TNF in mice. J Immunol (1996); 157: 5126-5129.
15. Maris NA, de Vos AF, Dessing MC, Spek CA, Lutter R, Jansen HM, van der Zee JS, Bresser P, van der Poll T. Antiinflammatory effects of salmeterol after inhalation of lipopolysaccharide by healthy volunteers. Am J Respir Crit Care Med (2005); 172: 878-884.
16. McLaughlin RF, Tueller EE. Anatomic and histologic changes of early emphysema. Chest (1971); 59: 592-599.
17. Michel O, Ginanni R, Le Bon B, Content J, Duchateau J, Sergysels R. Inflammatory response to acute inhalation of endotoxin in asthmatic patients. Am Rev Respir Dis (1992); 146: 352-357.
18. Michel O, Duchateau J, Plat G, Cantinieaux B, Hotimsky A, Gerain J, Sergysels R. Blood inflammatory response to inhaled endotoxin in normal subjects. Clin Exp Allergy (1995); 25: 73-79.
19. Michel O, Nagy AM, Schroeven M, Duchateau J, Nève J, Fondu P, Sergyels R. Dose-response relationship to inhaled endotoxin in normal subjects. Am J Respir Crit Care Med (1997); 156: 1157-1164.
20. Michel O, Dentener M, Corazza F, Buurman W, Rylander R. Healthy subjects express differences in clinical responses to inhaled lipopolysaccharide that are related with inflammation and with atopy. J Allergy Clin Immunol (2001); 107: 797-804.
21. Michel O, Dentener M, Cataldo D, Cantinieaux B, Vertongen F, Delvaux C, Murdoch RD. Evaluation of oral corticosteroids and phosphodiesterase-4 inhibitor on the acute inflammation induced by inhaled lipopolysaccharide in human. Pulm Pharmacol Ther (2007); 20: 676-683.
22. Mukhopadhyay S, Hoidal JR, Mukherjee TK. Role of TNFα in pulmonary pathophysiology. Respir Res (2006); 7: 125.
23. Nathan CF. Secretory products of macrophages. J Clin Invest (1987); 79: 319-326.
24. Nightingale JA, Rogers DF, Barnes PJ. Effect of repeated sputum induction on cell counts in normal volunteers. Thorax (1998a); 53: 87-90.
25. Nightingale JA, Rogers DF, Hart LA, Kharitonov SA, Chunf KF, Barnes PJ. Effect of inhaled endotoxin on induced sputum in normal, atopic and atopic asthmatic subjects. Thorax (1998b); 53: 563-571.
26. Nita I, Hollander C, Westin U, Janciauskiene SM. Prolastin, a pharmaceutical preparation of purified human α1-antitrypsin, blocks endotoxin-mediated cytokine release. Respir Res (2005); 6: 12.
27. Olsen GN, Harris JO, Castle JR, Waldman RH, Karmgard HJ. Alpha-1-antitrypsin content in serum, alveolar macrophages, and alveolar lavage fluid of smoking and non-smoking normal subjects. J Clin Invest (1975); 55: 427-430.
28. Rutgers SR, Postma DS, ten Hacken NH, Kauffman HF, van der Mark TW, Koeter GH, Timens W. Ongoing airway inflammation in patients with COPD who do not currently smoke. Thorax (2000); 55: 12-18.
29. Sandström T, Bjermer L, Rylander R. Lipopolysaccaride (LPS) inhalation in healthy subjects increases neutrophils, lymphocytes and fibronectin levels in bronchoalveolar lavage fluid. Eur Respir J (1992); 5: 992-996.
30. Stone PJ, Gottlieb DJ, O'Connor GT, Ciccolella DE, Breuer R, Bryan-Rhadfi J, Shaw HA, Franzblau C, Snider GL. Elastin and collagen degradation products in urine of smokers with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1995); 151: 952-959.
31. Thörn J, Rylander R. Inflammatory response after inhalation of bacterial endotoxin assessed by the induced sputum technique. Thorax (1998); 53: 1047-1052.
32. Viglio S, Iadarola P, Lupi A, Trisolini R, Tinelli C, Balbi B, Grassi V, Worlitzsch D, Doring G, Meloni F, Meyer KC, Dowson L, Hill SL, Stockley RA, Luisetti M. MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patients. Eur Respir J (2000); 15: 1039-1045.
33. Wallin A, Pourazar J, Sandström T. LPS-induced bronchoalveolar neutrophilia; effects of salmeterol treatment. Respir Med (2004); 98: 1087-1092.
34. Widegren H, Korsgren M, Andersson M, Greiff L. Effects of TNFα on the human nasal mucosa in vivo. Respir Med (2007); 101: 1982-1987.